Stevanato Group S.p.A (STVN) Capital Expenditures Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | -11.41% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 9.65% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 61.83% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | -63.39% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 14.32% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 21.73% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 12.30% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 15.01% |
| 10 | Stevanato Group S.p.A | 5.73 Bn | 5.59 Bn | 88.04 Mn | -4.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.77% |
| Dec 31, 2025 | -9.42% |
| Sep 30, 2025 | -11.11% |
| Jun 30, 2025 | 11.88% |
| Mar 31, 2025 | 32.21% |
| Dec 31, 2024 | -7.67% |
| Sep 30, 2024 | 65.84% |
| Jun 30, 2024 | 26.29% |
| Mar 31, 2024 | 20.34% |
| Dec 31, 2023 | -27.36% |
| Sep 30, 2023 | -250.89% |
| Jun 30, 2023 | -27.15% |
| Mar 31, 2023 | -131.61% |
| Dec 31, 2022 | -66.82% |
| Sep 30, 2022 | -26.49% |
| Jun 30, 2022 | -194.03% |
| Mar 31, 2022 | -125.84% |
| Dec 31, 2021 | -20.93% |
| Sep 30, 2021 | -42.04% |
| Jun 30, 2021 | -1.29% |